The future of combination vaccines

The development of combination vaccines could greatly improve public health preparedness. These vaccines streamline the vaccination process and provide broader protection. Moderna is using its mRNA platform to develop vaccines targeting multiple respiratory viruses simultaneously, including COVID-19, RSV, and influenza. The technology allows the immune system to combat multiple pathogens at once, enhancing public health preparedness.